Lyra Therapeutics

Biotechnology firm innovating localized therapies for chronic rhinosinusitis (CRS)

placeWatertown, Massachusetts, United States calendar_todayFounded 2005 groups75 employees language lyratherapeutics.com

Registered entities

Investor mix

11 investors on record; lead investors include Perceptive Advisors.

Investor typeCountShare
Venture capital655%
Private equity218%
Other / undisclosed327%
Coming soon